284 related articles for article (PubMed ID: 8857005)
1. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
Gill PS; McLaughlin T; Espina BM; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo RC
J Natl Cancer Inst; 1997 Dec; 89(23):1797-802. PubMed ID: 9392621
[TBL] [Abstract][Full Text] [Related]
4. Beta-human choriogonadotropin therapy and HIV-related Kaposi's sarcoma.
Witzke O; Hense J; Reinhardt W; Reiner C; Hoermann R; Philipp T
Eur J Med Res; 1997 Apr; 2(4):155-8. PubMed ID: 9110921
[TBL] [Abstract][Full Text] [Related]
5. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
Amantea MA; Forrest A; Northfelt DW; Mamelok R
Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadtropin.
Smart T
GMHC Treat Issues; 1995; 9(7/8):15. PubMed ID: 11362654
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
9. HCG: new kind of KS treatment?
James JS
AIDS Treat News; 1996 Nov; (No 258):1-3. PubMed ID: 11363995
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
Dezube BJ; Krown SE; Lee JY; Bauer KS; Aboulafia DM
J Clin Oncol; 2006 Mar; 24(9):1389-94. PubMed ID: 16549833
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight components but not dimeric HCG inhibit growth and down-regulate AP-1 transcription factor in Kaposi's sarcoma cells.
Kachra Z; Guo WX; Sairam MR; Antakly T
Endocrinology; 1997 Sep; 138(9):4038-41. PubMed ID: 9275098
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A; Scadden DT; Lee J; Dezube BJ; Aboulafia D; Tulpule A; Walmsley S; Gill P
J Clin Oncol; 2005 Feb; 23(5):990-8. PubMed ID: 15598977
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
[TBL] [Abstract][Full Text] [Related]
14. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
[TBL] [Abstract][Full Text] [Related]
15. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma--what's human chorionic gonadotropin got to do with it?
Krown SE
N Engl J Med; 1996 Oct; 335(17):1309-10. PubMed ID: 8857012
[No Abstract] [Full Text] [Related]
17. Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057.
Miles S; Levine A; Feldstein M; Carden J; Cabriallas S; Marcus S; Mitsuyasu R; Gill P
Cytokines Cell Mol Ther; 1998 Mar; 4(1):17-23. PubMed ID: 9557213
[TBL] [Abstract][Full Text] [Related]
18. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
19. [The value of conventionally fractionated radiotherapy in the local treatment of HIV-related Kaposi's sarcoma].
Saran F; Adamietz IA; Mose S; Thilmann C; Böttcher HD
Strahlenther Onkol; 1995 Oct; 171(10):594-9. PubMed ID: 8571179
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.
Bisacchi D; Noonan DM; Carlone S; Albini A; Pfeffer U
Biol Chem; 2002 Sep; 383(9):1315-20. PubMed ID: 12437123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
